Mr Ronald F Helwig, PT | |
5606 Jefferson Hwy, Harahan, LA 70123-5111 | |
(504) 733-0254 | |
(504) 734-8869 |
Full Name | Mr Ronald F Helwig |
---|---|
Gender | Male |
Speciality | Physical Therapy |
Experience | 25 Years |
Location | 5606 Jefferson Hwy, Harahan, Louisiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013994771 | NPI | - | NPPES |
1801143 | Medicaid | LA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | PT 04386 (Louisiana) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Magnolia Physical Therapy, Llc | 6204854078 | 9 |
News Archive
The first study to investigate risk factors for the vascular condition called CCSVI (chronic cerebrospinal venous insufficiency) in volunteers without neurological disease has identified what the researchers call a remarkable similarity between this condition and possible or confirmed risk factors for multiple sclerosis.
OPKO Health, Inc. today announced that it has entered into a definitive agreement with Schering-Plough Corporation to acquire assets relating to Schering's neurokinin-1 (NK-1) receptor antagonist program. Rolapitant, the lead product, recently completed Phase II clinical testing for prevention of nausea and vomiting related to cancer chemotherapy and surgery, and other indications.
Echo Therapeutics, Inc., a medical device company developing its Symphony CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that it entered into a strategic collaboration agreement with Medical Technologies Innovation Asia, Ltd., Hong Kong, for a license arrangement and equity investment in Echo.
Sen. Edward Kennedy (D-Mass.) on Monday at a forum co-sponsored by the Alliance for Health Reform and the Robert Wood Johnson Foundation said that Congress likely will have the ability to authorize the $50 billion over five years needed to enroll all children eligible for SCHIP but "hedged on whether it would do so this year or over the next several years," CQ HealthBeat reports.
A thin ring inserted into the eye could soon offer a reading glasses-free remedy for presbyopia, the blurriness in near vision experienced by many people over the age of 40, according to a study released today at AAO 2014, the 118th annual meeting of the American Academy of Ophthalmology.
› Verified 4 days ago
Provider Name | Magnolia Physical Therapy, Llc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1316083447 PECOS PAC ID: 6204854078 Enrollment ID: O20051110000091 |
News Archive
The first study to investigate risk factors for the vascular condition called CCSVI (chronic cerebrospinal venous insufficiency) in volunteers without neurological disease has identified what the researchers call a remarkable similarity between this condition and possible or confirmed risk factors for multiple sclerosis.
OPKO Health, Inc. today announced that it has entered into a definitive agreement with Schering-Plough Corporation to acquire assets relating to Schering's neurokinin-1 (NK-1) receptor antagonist program. Rolapitant, the lead product, recently completed Phase II clinical testing for prevention of nausea and vomiting related to cancer chemotherapy and surgery, and other indications.
Echo Therapeutics, Inc., a medical device company developing its Symphony CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that it entered into a strategic collaboration agreement with Medical Technologies Innovation Asia, Ltd., Hong Kong, for a license arrangement and equity investment in Echo.
Sen. Edward Kennedy (D-Mass.) on Monday at a forum co-sponsored by the Alliance for Health Reform and the Robert Wood Johnson Foundation said that Congress likely will have the ability to authorize the $50 billion over five years needed to enroll all children eligible for SCHIP but "hedged on whether it would do so this year or over the next several years," CQ HealthBeat reports.
A thin ring inserted into the eye could soon offer a reading glasses-free remedy for presbyopia, the blurriness in near vision experienced by many people over the age of 40, according to a study released today at AAO 2014, the 118th annual meeting of the American Academy of Ophthalmology.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Ronald F Helwig, PT 5606 Jefferson Hwy, Harahan, LA 70123-5111 Ph: (504) 733-0254 | Mr Ronald F Helwig, PT 5606 Jefferson Hwy, Harahan, LA 70123-5111 Ph: (504) 733-0254 |
News Archive
The first study to investigate risk factors for the vascular condition called CCSVI (chronic cerebrospinal venous insufficiency) in volunteers without neurological disease has identified what the researchers call a remarkable similarity between this condition and possible or confirmed risk factors for multiple sclerosis.
OPKO Health, Inc. today announced that it has entered into a definitive agreement with Schering-Plough Corporation to acquire assets relating to Schering's neurokinin-1 (NK-1) receptor antagonist program. Rolapitant, the lead product, recently completed Phase II clinical testing for prevention of nausea and vomiting related to cancer chemotherapy and surgery, and other indications.
Echo Therapeutics, Inc., a medical device company developing its Symphony CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that it entered into a strategic collaboration agreement with Medical Technologies Innovation Asia, Ltd., Hong Kong, for a license arrangement and equity investment in Echo.
Sen. Edward Kennedy (D-Mass.) on Monday at a forum co-sponsored by the Alliance for Health Reform and the Robert Wood Johnson Foundation said that Congress likely will have the ability to authorize the $50 billion over five years needed to enroll all children eligible for SCHIP but "hedged on whether it would do so this year or over the next several years," CQ HealthBeat reports.
A thin ring inserted into the eye could soon offer a reading glasses-free remedy for presbyopia, the blurriness in near vision experienced by many people over the age of 40, according to a study released today at AAO 2014, the 118th annual meeting of the American Academy of Ophthalmology.
› Verified 4 days ago
Michael Harvey, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1200 S Clearview Pkwy Ste 200, Harahan, LA 70123 Phone: 504-736-4734 | |
Janice Coleman Albert, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 5606 Jefferson Hwy, Harahan, LA 70123 Phone: 504-733-0254 Fax: 504-734-8869 | |
Anthony Nguyen, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 5606 Jefferson Hwy, Harahan, LA 70123 Phone: 504-733-0254 | |
Brianna Rauch, Physical Therapist Medicare: Medicare Enrolled Practice Location: 5606 Jefferson Hwy, Harahan, LA 70123 Phone: 504-733-0254 Fax: 504-734-8869 | |
Mr. Chris Dysart, DPT Physical Therapist Medicare: May Accept Medicare Assignments Practice Location: 1827 Hickory Ave Ste B, Harahan, LA 70123 Phone: 504-360-2584 Fax: 504-360-2084 | |
Louisiana Physical Therapy Services Of Harahan, Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 7904 Jefferson Hwy, Suite 105, Harahan, LA 70123 Phone: 504-229-7044 Fax: 504-229-7046 |